FDA hearing on flibanserin

Text Size: Normal / Medium / Large
Printer-friendly versionPrinter-friendly version
Resource Language: 
New View Campaign
New View Campaign wesite
Publication Date: 

Read the New View Campaign’s comments on US FDA hearings for approval of Flibanserin:

“On June 18, 2010, the FDA Reproductive Health Advisory Committee convenes for the second time to consider a drug for "female sexual dysfunction" (the first drug, Intrinsa, failed in 2004). The New View Campaign opposes the approval of flibanserin, and is preparing factsheets and petitions, has spoken to endless media, and will be participating in the hearing as part of the section on public speakers. In combination with the materials we prepared in 2004 for the Intrinsa hearing, these resources offer a rich analysis of the medicalization of sexuality.”

Available From: 
Order Information: 
Available online.